← Back to guidelines
Allergy & Immunology5 papers

March hemoglobinuria

Last edited: 4/15/2026

Overview

March hemoglobinuria refers to a condition characterized by the presence of hemoglobin in the urine, often associated with erythrocyte membrane protein anomalies as identified through high-resolution electrophoresis 2.

Diagnosis

  • Utilize high-resolution sodium-dodecyl-sulphate/polyacrylamide-gel electrophoresis to detect erythrocyte membrane protein abnormalities 2.
  • Consider variability in fecal sampling techniques and their impact on quantitative fecal immunochemical tests for hemoglobin (FIT-Hb) when evaluating related conditions, though not directly applicable to urine analysis 1.
  • Management

  • No specific first-line treatments are detailed in the provided abstracts. Management likely focuses on addressing underlying causes 2.
  • Adjunctive management may involve supportive care tailored to underlying pathology, though specific drug classes or doses are not mentioned 2.
  • Special Populations

  • No specific guidance provided for pregnancy, pediatrics, elderly, or comorbidities related to march hemoglobinuria in the given abstracts 12.
  • Key Recommendations

  • Employ high-resolution sodium-dodecyl-sulphate/polyacrylamide-gel electrophoresis for diagnosing erythrocyte membrane protein anomalies in suspected march hemoglobinuria cases (Evidence: Moderate) 2.
  • Be aware of preanalytical variability in sampling techniques, particularly in related diagnostic tests, though direct application to march hemoglobinuria management is limited (Evidence: Weak) 1.
  • Tailor management strategies to address underlying causes of march hemoglobinuria, given the lack of specific therapeutic guidelines (Evidence: Expert opinion) 2.
  • References

    1 Rapi S, Berardi M, Cellai F, Ciattini S, Chelazzi L, Ognibene A et al.. Effects of fecal sampling on preanalytical and analytical phases in quantitative fecal immunochemical tests for hemoglobin. The International journal of biological markers 2017. link 2 Banga JP, Pinder JC, Gratzer WB, Linch DC, Huehns ER. An erythrocyte membrane-protein anomaly in march haemoglobinuria. Lancet (London, England) 1979. link92444-9)

    Original source

    1. [1]
      Effects of fecal sampling on preanalytical and analytical phases in quantitative fecal immunochemical tests for hemoglobin.Rapi S, Berardi M, Cellai F, Ciattini S, Chelazzi L, Ognibene A et al. The International journal of biological markers (2017)
    2. [2]
      An erythrocyte membrane-protein anomaly in march haemoglobinuria.Banga JP, Pinder JC, Gratzer WB, Linch DC, Huehns ER Lancet (London, England) (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG